UBS Group’s Blend Labs BLND Stock Holding History

UBS Group’s Portfolio BLND Stock Details BLND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-94,400	Closed	-$136K	–	9625
2022 Q4	$136K	Buy	+94,400	New	+$169K	﹤0.01%	5808

Other funds holding BLND

HIM

Haveli Investment Management Austin, Texas $180M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CPIM

Cypress Point Investment Management Mill Valley, California $552M AUM

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Whitebark Investors Incline Village, Nevada $129M AUM 26.3% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group's BLND Position: Q2 2026 in Review

UBS Group reduced its Blend Labs (BLND) stake by 13% in Q2 2026, selling an estimated $145K and leaving 635,392 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #5663.

UBS Group first reported a position in BLND in Q4 2021 and has held it in 17 quarters since. The position peaked at $2M in Q2 2025. 183 funds tracked by Wall St. Rank hold BLND as of Q2 2026.

UBS Group held 635,392 shares of Blend Labs worth $1.09M as of Q2 2026.
UBS Group sold 91,036 Blend Labs shares in Q2 2026, an estimated $145K.
Blend Labs made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5663 holding.
UBS Group first reported a position in Blend Labs in Q4 2021 and has held it in 17 quarters since.
UBS Group's Blend Labs position peaked at $2M in Q2 2025.
183 funds tracked by Wall St. Rank held Blend Labs as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.